http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101888779-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S514-866 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 |
| filingDate | 2015-04-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101888779-B1 |
| titleOfInvention | Use of isoquinoline alkaloid derivative for preparing drug capable of promoting ampk activity |
| abstract | The use of isoquinoline alkaloid derivatives for the manufacture of medicaments having the potency to activate AMP-dependent protein kinase (AMPK) is described. The isoquinoline alkaloid derivative may be salicolinol or reticuline. Drugs can activate AMPK, and thus can be used to regulate cell growth and metabolism and treat AMPK-related diseases. |
| priorityDate | 2014-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.